教員業績データベース |
|
論文種別 | 原著 |
言語種別 | 英語 |
査読の有無 | 査読あり |
表題 | The Nonsteroidal Anti-inflammatory Drug Diclofenac Reduces Acid-Induced Heartburn Symptoms in Healthy Volunteers. |
掲載誌名 | 正式名:Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 略 称:Clin Gastroenterol Hepatol ISSNコード:1542-7714(Electronic)1542-3565(Linking) |
巻・号・頁 | 13(7),pp.1249-1255 |
著者・共著者 | Kondo Takashi, Oshima Tadayuki, Tomita Toshihiko, Fukui Hirokazu, Okada Hiroki, Watari Jiro, Miwa Hiroto |
発行年月 | 2015/07 |
概要 | BACKGROUND & AIMS:We investigated the effects of diclofenac, a nonsteroidal anti-inflammatory drug that inhibits prostaglandin production, on induction of esophageal sensation by acid perfusion in healthy men.METHODS:We performed a prospective, double-blind, placebo-controlled, 2-period, cross-over study over 3 visits in 12 healthy men. Diclofenac was given 6 hours and 2 hours before an acid perfusion test. During the test, hydrochloric acid (0.15 mol/L) was perfused into the lower esophagus for 30 minutes; we evaluated upper gMETHODS:astrointestinal symptoms using a validated categoric rating scale. Then, we calculated and assessed the acid perfusion sensitivity score (APSS). Biopsy specimens were collected by endoscopy of the distal esophagus before and after acid perfusion; levels of prostaglandin E2 (PGE2) (pg/mg) were measured in the samples using an enzyme-linked immunosorbent assay.RESULTS:Compared with placebo, diclofenac significantly reduced the APSS for heartburn (82.2 ± 12.2 for placebo and 47.5 ± 8.9 for diclofenac; PRESULTS:<RESULTS:.01). Of the upper gastrointestinal symptoms, only the APSS for heartburn was reduced significantly by diclofenac. Compared with placebo, diclofenac reduced the overproduction of PGE2 by esophageal tissues after acid perfusion (23.3 ± 5.2 for placebo and 11.4 ± 3.5 for diclofenac; PRESULTS:<RESULTS:.05). APSS correlated with the development of heartburn and esophageal levels of PGE2 (r = 0.53; PRESULTS:<RESULTS:.05 for heartburn vs PGE2).CONCLUSIONS:Diclofenac attenuated acid-induced heartburn by inhibiting PGE2 overproduction in the esophagus. Esophageal PGE2 might be involved in producing heartburn symptoms. Clinical Trials Registry no: UMIN000014595. |
DOI | 10.1016/j.cgh.2015.01.014 |
PMID | 25632805 |